Back to search
FDAFDA · Food and drugs·Recall number D-393-2014

Fosinopril Sodium and Hydrochlorothiazide Tablets, 10 mg/12.5 mg, Rx Only, 100 Tablets, Sandoz Inc. Princeton, NJ 08540 ---NDC 0185-0341-01,

Published January 8, 2014 · Recall initiated: October 11, 2013

Summary

FDA records drug Class II recall D-393-2014, published January 8, 2014 and initiated October 11, 2013. Recalling firm: Sandoz Inc; Status: Terminated; Reported quantity: 2,491 bottles of 100 tablets each; Lot: Lot CU0856. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Subpotent; Hydrochlorothiazide at the 9 month time point.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sandoz Inc
Distributor
Nationwide
Lot
Lot CU0856
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Fosinopril Sodium and Hydrochlorothiazide Tablets, 10 mg/12.5 mg, Rx Only, 100 Tablets, Sandoz Inc. Princeton, NJ 08540 ---NDC 0185-0341-01, recalled?

Yes. FDA published recall D-393-2014 on January 8, 2014. Reported hazard: Subpotent; Hydrochlorothiazide at the 9 month time point.

What should I do if I have this product?

Voluntary: Firm initiated · Letter